GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emmessar Biotech And Nutrition Ltd (BOM:524768) » Definitions » Cost of Goods Sold

Emmessar Biotech And Nutrition (BOM:524768) Cost of Goods Sold : ₹2.02 Mil (TTM As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Emmessar Biotech And Nutrition Cost of Goods Sold?

Emmessar Biotech And Nutrition's cost of goods sold for the three months ended in Dec. 2024 was ₹0.32 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Dec. 2024 was ₹2.02 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Emmessar Biotech And Nutrition's Gross Margin % for the three months ended in Dec. 2024 was 66.56%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Emmessar Biotech And Nutrition's Inventory Turnover for the three months ended in Dec. 2024 was 0.60.


Emmessar Biotech And Nutrition Cost of Goods Sold Historical Data

The historical data trend for Emmessar Biotech And Nutrition's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emmessar Biotech And Nutrition Cost of Goods Sold Chart

Emmessar Biotech And Nutrition Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cost of Goods Sold
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.41 35.32 1.26 4.00 1.98

Emmessar Biotech And Nutrition Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 0.19 0.23 1.28 0.32

Emmessar Biotech And Nutrition Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Emmessar Biotech And Nutrition  (BOM:524768) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Emmessar Biotech And Nutrition's Gross Margin % for the three months ended in Dec. 2024 is calculated as:

Gross Margin %=(Revenue - Cost of Goods Sold) / Revenue
=(0.96 - 0.321) / 0.96
=66.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Emmessar Biotech And Nutrition's Inventory Turnover for the three months ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Emmessar Biotech And Nutrition Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Emmessar Biotech And Nutrition's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Emmessar Biotech And Nutrition Business Description

Traded in Other Exchanges
N/A
Address
38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001
Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.

Emmessar Biotech And Nutrition Headlines

No Headlines